Doctor profile · Federal record
Dr. Annette Lusko, D.O
Family Medicine Physician (CMS: Family Practice) · Family Medicine Physician · Mesa, AZ
- NPI 1487918181
- Accepts Medicare
- 14 yrs in practice
- Licensed in 2 states
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1855 W Baseline RD Ste 101
Mesa, AZ 852029098
(480) 507-3188
Credentials & registration
- NPI registered
- June 2012 — 14 yrs on file
- Profile last updated
- May 8, 2018
- Year of graduation
- 2012 — 14 yrs since
- Specialty taxonomy
- 207Q00000X — NUCC code
- State licenses (2)
- Arizona #006726 · Indiana #11016763A
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1487918181. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
53
Distinct HCPCS
2
Medicare allowed
$1,278
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
87426 |
Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | 28 | 11 | $35 | |
80305 |
Testing for presence of drug, read by direct observation | 25 | 18 | $12 |
In context: peer comparison
Among 62 peers in Mesa Family Medicine Physician, average services per provider: 127. This provider delivers 0.4× the peer median.Frequently asked questions
What is Dr. Annette Lusko's medical specialty?
Dr. Annette Lusko practices Family Medicine Physician in Mesa, AZ.
Where does Dr. Annette Lusko practice?
Dr. Annette Lusko practices at 1855 W Baseline RD Ste 101, Mesa, AZ 852029098. Office phone: 4805073188.
What is Dr. Annette Lusko's NPI?
Dr. Annette Lusko's National Provider Identifier (NPI) is 1487918181, issued by NPPES.
Does Dr. Annette Lusko accept Medicare assignment?
Yes. Dr. Annette Lusko accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Annette Lusko commonly perform?
Top Medicare-reported procedures in 2023: Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus (HCPCS 87426); Testing for presence of drug, read by direct observation (HCPCS 80305). Source: CMS Medicare Physician & Other Practitioners file.